As per the report “Global Medical Membrane Market – Industry Dynamics, Market Size, and Opportunity Forecast to 2030” published by Astute Analytica, the market has been expected to grow at a CAGR of 10.1% over the forecast period 2022-2030.
Get a Free Sample Copy of this Report@ https://www.astuteanalytica.com/request-sample/medical-membrane-market
The research study analyzes the impact of some of the major market drivers such as the increasing cases of kidney disorders. More than 1 in 7, that is 15% of US adults or 37 million people, are estimated to have Chronic Kidney Disease (CDK). CKD affects people of all ages and gender; however, it is more common in the elderly population. In adults aged 64 and up, the prevalence is estimated to be 23–36% worldwide. It’s a global public health issue that’s linked to lower quality of life and shorter life expectancy in people of all ages.
Surge in demand for high-purity products, developments in biotechnology, life science, and healthcare industries and increasing demand for artificial organs are the other factors that are driving the market growth. In comparison to the number of donors donating organs, the number of patients requiring an organ transplant is steadily increasing. The demand for organ transplants is rapidly outpacing availability. As of August 2017, more than 116,000 people were on the waiting list for an organ transplant, according to the US Department of Organ Donation and Transplantation, with around 30% of those receiving a transplant. Although 95% of persons in the United States support organ donation, only 54% actually donate. Renal replacement therapy is in significant demand in the United States, Japan, Germany, Brazil, and Italy. Approximately 1.5 million of these two million persons require dialysis. Dialysis patients have an annual growth rate of greater than 7-8 percent. Medical membranes are in high demand as a result of this expansion. Other artificial organs, such as pancreases and liver, are also in high demand. Medical membranes are also being driven by the desire for artificial organs that utilize membranes.
However, the long in-process validation process, shorter lifespan of membrane, and regulatory barriers by the FDA seem to obstruct the market growth. Despite the high demand for medical products and devices, the FDA’s multi-layered regulations have created various regulatory impediments for companies. Manufacturers must submit performance data to the FDA for approval of every new medical product in the United States. The device is compared to a lawfully marketed device for the same use and with the same technological attributes in this process. As a result, the commercialization of medical membranes and medical goods is delayed due to the lengthy validation and certification process. Medical membranes used in a variety of operations are prone to fouling, after which they lose their effectiveness. Unwanted components such as iron, manganese, calcium, sulfate, and other ions create precipitates on the membrane surface during the treatment of pharmaceutical water or any filtration/purification procedure. The membrane’s characteristics are being harmed. As a result, the high maintenance cost of medical membranes is also limiting market expansion.
Technological Advancements in Medical Membrane generates profitable opportunity in the market
New membranes and biological membranes would be developed as a result of technological advancement in the market. Furthermore, the self-sufficiency rate of traditional membrane raw materials will be significantly improved; novel membrane materials, such as polymers with intrinsic microporosities (PIMs), organic framework (MOF/COF) materials, polymethylpentene (PMP), molecular-sieve membrane materials, polyarylene sulphide, and other special separation membrane materials, has been developed and corresponding technologies for preparing membranes and equipment is introduced by key manufacturers of medical membranes.
Hollow fibre membrane (HFM) is a new product of membrane technology, which is formed via the intersection of functional fibre material and separation membrane technologies. HFM is widely employed in biomedical fields, such as the designs of artificial kidneys (haemodialysis), artificial lungs (oxygenation membranes), separation of blood components, and the separation and purification of Chinese and Western medicines. Extracorporeal membrane oxygenation (ECMO), well-known critical equipment for treating the cardiopulmonary system during the outbreak of the coronavirus disease 2019, has been researched, developed, and produced only by <10 manufacturers, such as Maquet Company (Germany), Medtronic Inc. (the United States), and Sorin Company (the United Kingdom).
Similarly, the applicability of the nanofiltration technique in new areas such as pharmaceuticals and fine chemicals has been extended by research & development of solvent-stable membranes. Nanostructure incorporation into polymeric membrane matrices to form nanocomposites membrane has become an important research area. For instance, porous nanocrystalline silicon membrane has been designed to pass middle molecular weight protein toxin while retaining albumin, mimicking the healthy kidney.
The 3M company combines decades of experience in membrane development and manufacture with deep knowledge of membrane module design and production. Spinning and make-up technologies, as well as polymer chemistry and biochemistry, are all covered by their membrane technology. They can deliver high-quality capillary and flat sheet membranes made of a variety of polymers, as well as modules adapted to the application’s specific needs because they control the design and construction. Membranes and modules are manufactured under cutting-edge conditions.
Growing demand for medical membranes in emerging countries
Geographically, the market for medical membranes is divided into five regions: North America, Europe, Asia Pacific, South America, and the Middle East and Africa (MEA). The market for medical membranes in emerging nations is being spurred by the requirement for ultra-pure water for pharmaceutical manufacture and hemodialysis. Emerging markets such as China, India, Brazil, and other developing countries offer enormous prospects for pharmaceutical manufacturers and dialysis treatment providers. The rising incidence of ESRD is driving up demand for dialysis goods and services in these nations. The need is also fueled by the aging population, rising diabetes, and hypertension rates, and increased awareness of kidney disease. Medical contract manufacturing is also becoming more popular in nations like India and China.
In China, the ERSD patients are increasing by 120 thousand each year, which requires more than 1.4 billion dollars for the maintenance of their survival and treatment. This has increased the demand for membranes used in hemodialysis.
Europe, on the other hand, is a global leader in pharmaceutical manufacture and demand for dialyzers. Its expansion is propelled by an increasing number of ESRD patients, improved diagnosis facilities, and the high incidence and prevalence of chronic conditions including diabetes and hypertension. Diabetes and hypertension were responsible for almost 60% of all ESRD cases in Europe.
Major players covered in this report are Asahi Kasei, Pall Corporation, 3M, Merck Millipore, Koch Membrane Systems, GE Healthcare, Sartorius AG, Hangzhou Cobetter Filtration Equipment, Microdyn-Nadir and W. L. Gore & Associates. The increase in the number of players and their contribution to the market acted as economic pillars to sustain the market’s expansion. For instance, In 2017, the 3M Company (US) invested USD 40.0 million to expand its dialysis membrane manufacturing facilities. This development will help the company expand its customer base and boost its position among the several medical device manufacturers who produce dialyzers. 3M Company (US) bought Polypore Separation from Polypore International in February 2015, allowing the company to reach out to a larger customer base with a more diverse product line.
Similarly, Merck Millipore (US) acquired Natrix Separation (Canada), a hydrogel membrane provider, in August 2017. Merck Millipore will benefit from this acquisition by expanding its product portfolio, client base, and strengthening its position in North America. The company began construction on a new facility in the United States in July 2016, which will feature a training center and a customer cooperation laboratory. It will assist the organization in producing innovative and customized solutions for various healthcare applications.
Market size analysis based on revenue and volume distribution in several segments is included in the report’s market segments. These include material, process technology, application, and region. The highest share of each segment is well illustrated in the report. For instance, pharmaceutical filtration is dominating the application segment in the market owing to the rise in the incidence of disease, advancement in the medical sector, and growing pharmaceutical and healthcare industries. Sartorius produces pharmaceutical-grade filters, membranes, and filter devices. Minisart syringe filters, for example, are perfect for clearing particle-laden liquids, such as pharmaceutical or infusion solution preparation. Syringe filters are ideal for sterile venting of containers, bioreactors, fermenters, and tubing systems in devices because they sterilize and remove particles from the air and other gases.
The report provides a thorough analysis of the Global Medical Membrane Market – Industry Dynamics, Market Size, and Opportunity Forecast to 2030, based on the following.
- Polytetrafluoroethylene (PTFE)
- Polyvinylidene fluoride (PVDF)
- Polypropylene (PP)
- Polysulfone (PSU)
- Polyether Sulfone (PESU)
By Process Technology
- Membrane filtration
- Reverse Osmosis
- Gas Filtration
- IV Infusion & Sterile Filtration
- Bio-artificial processes
- Drug Delivery
- Pharmaceutical Filtration
- North America
- The UK
- Rest of Europe
- Asia Pacific
- Australia & New Zealand
- Rest of Asia Pacific
- Middle East & Africa (MEA)
- Saudi Arabia
- South Africa
- Rest of MEA
- South America
- Rest of South America
Access Full Report@ https://www.astuteanalytica.com/request-sample/medical-membrane-market
About Astute Analytica
Astute Analytica is a global analytics and advisory company which has built a solid reputation in a short period, thanks to the tangible outcomes we have delivered to our clients. We pride ourselves in generating unparalleled, in depth and uncannily accurate estimates and projections for our very demanding clients spread across different verticals. We have a long list of satisfied and repeat clients from a wide spectrum including technology, healthcare, chemicals, semiconductors, FMCG, and many more. These happy customers come to us from all across the Globe. They are able to make well calibrated decisions and leverage highly lucrative opportunities while surmounting the fierce challenges all because we analyze for them the complex business environment, segment wise existing and emerging possibilities, technology formations, growth estimates, and even the strategic choices available. In short, a complete package. All this is possible because we have a highly qualified, competent, and experienced team of professionals comprising of business analysts, economists, consultants, and technology experts. In our list of priorities, you-our patron-come at the top. You can be sure of best cost-effective, value-added package from us, should you decide to engage with us.
BSI Business Park, H-15,Sector-63, Noida- 201301- India
Phone: +1-888 429 6757 (US Toll Free); +91-0120- 4483891 (Rest of the World)
Follow US: LinkedIn | Twitter